Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 23;11(7):e5219.
doi: 10.7759/cureus.5219.

Correlation Between Body Mass Index and Fibroadenoma

Affiliations

Correlation Between Body Mass Index and Fibroadenoma

Mehreen K Bhettani et al. Cureus. .

Abstract

Introduction Among all benign conditions, the fibroadenoma is the most common lesion worldwide as well as in Pakistan. Clinicians often face the dilemma of whether to remove the mass or to monitor it by means of periodic follow-up examinations. Although the removal of these lesions is a definitive solution, surgery may involve unnecessary excision of benign lesions and unbecoming cosmesis. Body mass index (BMI) is a known risk factor for the development of breast cancer.However, the relationship between BMI and benign breast diseases is still unclear. Some studies showed that increased BMI is a risk factor for benign breast diseases; however, a large number of studies showed that a decrease in BMI is the risk factor for benign breast diseases. Material and methods This was a descriptive cross-sectional study conducted at the Department of General Surgery, Pakistan Institute of Medical Sciences (PIMS), Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, Pakistan. All patients fulfilling inclusion criteria were assessed in the breast clinic of PIMS. A final diagnosis of fibroadenoma was made after a triple assessment. Weight in kilograms and height in meters were measured. All the information was recorded in a specifically designed proforma accordingly by the postgraduate trainee. BMI was calculated by the formula: BMI=Weight in kgs/height in meters. Other variables that were noted include patients' age, gender, contact number, and hospital visit. The data were analyzed using SPSS version 21 (IBM Corp., Armonk, NY, US). Results The BMI of study patients was 21.8 ± 1.3, ranging from 19 to 24.9. Out of 300 patients presenting with benign breast disease, 60 (20%) had a fibroadenoma while 240 (80%) had other benign breast diseases. Out of 136 patients with high BMI, 42 (30.8%) had a fibroadenoma while out of 74 patients with low BMI, eight (10.8%) had a fibroadenoma; however, out of 90 patients with normal BMI, 10 (11.1%) had a fibroadenoma. Our study population showed an increased risk of fibroadenoma formation in the adolescent age group with an OR value of 8.54 (CI 4.38-16.63, P<0.001). There were also additional statistical correlations between higher BMI and the site of the lesion being the upper outer quadrant of the breast (t= 4.326 P<0.01). There was no significant correlation of BMI with size and increased number of lesions (P=0.280 and P=0.175). Conclusion High BMI seems to be a substantial risk factor for the development of a fibroadenoma, particularly in young adolescent females.

Keywords: adolescent; body mass index; breast cancer; breast neoplasms; excision; fibro adenoma; obesity; public awareness; surgery.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Correlation of BMI with the site of lesion (p<0.05), (1 = UOQ, 2 = LOQ, 3 = UIQ, 4 = LIQ)
BMI: body mass index; UOQ: upper outer quadrant; LOQ: lower outer quadrant; UIQ: upper inner quadrant; LIQ: lower inner quadrant

Similar articles

Cited by

References

    1. Benign breast disorders. Santen RJ, Mansel R. N Engl J Med. 2005;353:275–285. - PubMed
    1. Benign breast disease, mammographic breast density, and the risk of breast cancer. Tice JA, O'Meara ES, Weaver DL, Vachon C, Ballard-Barbash R, Kerlikowske K. J Natl Cancer Inst. 2013;105:1043–1049. - PMC - PubMed
    1. Clinical study on fibroadenoma of the breast. Rangaswamy P, Rubby S. Int Surg J. 2016;3:1916–1919.
    1. Benign breast diseases: experience at a teaching hospital in rural India. Abhijit MG, Anantharaman D, Sumanth B, Ranjani R. IntJ Res Med Sci. 2013;1:73–78.
    1. European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition—summary document. Perry N, Broeders M, de Wolf C, Tornberg S, Holland R, von Karsa L. Ann Oncol. 2008;19:614–622. - PubMed

LinkOut - more resources